Volume 34, Issue 3, September 2023

Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2023;34(1):66-70
The Prevalence of Behçet’s Disease in a Thrombosis Clinic
Authors Information

1Department of Internal Medicine, Rheumatology Division, American University of Beirut, Beirut, Lebanon

2CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal

3Dumfries & Galloway Royal Infirmary, Dumfries, Scotland, United Kingdom

P Ames 

  1. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR ICBD), Davatchi F, Assaad-Khalil S, Calamia KT et al. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338-47.
  2. Kaklamani VG, Kaklamanis PG. Behçet’s disease. Semin Arthritis Rheum 1998;27:197-217.
  3. Kidd D. The prevalence of Behçet's syndrome and its neurological complications in Hertfordshire, U.K. Adv Exp Med Biol 2003;528:95-7.
  4. Desbois AC, Wechsler B, Cluzelc P et al. Cardiovascular involvement in Behçet’s disease. Rev Méd Inter 2014;35:103-11.
  5. Sarica-Kucukoglu R, Akdag-Kose A, KayabalI M et al. Vascular involvement in Behçet’s disease: a retrospective analysis of 2319 cases. Int J Dermatol 2006;45:919-21.
  6. Seaman G, Pearce R. Behçet’s Disease manifestation in a population drawn from the UK Behçet’s Syndrome Society. Hamza M (ed). Behçet’s Disease. Tunisia: Pub Adhoua; 1997:196-9.
  7. Ames PRJ, Steuer A, Pap A, Denman AM. Thrombosis in Behçet’s disease: a retrospective survey from a single UK centre. Rheumatology 2001;40:652-5.
  8. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191-4.
  9. http://www.hra-decisiontools.org.uk/ethics/
  10. Gogus F, Tumer NB, Günendi Z, Iriz E, Imren VY, Oktar GL. Prevalence of Behçet’s syndrome in patients presenting with venous thrombosis: prospective study in a cardiovascular outpatient clinic. Arch Med Sci 2009;5,3:371-5.
  11. Yazici H, Yurdakul S, Hamuryudan V. Behçet’s syndrome. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds). Oxford Textbook of Rheumatology. Oxford, Oxford University Press 1998;1394-402.
  12. Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008;58:3951–9.
  13. Lukas PS, Krummenacher R, Biasiutti FD, Begré S, Znoj H, von Känel R. Association of fatigue and psychological distress with quality of life in patients with a previous venous thromboembolic event. Thromb Haemost 2009;102:1219-26
  14. Busuttil A, Lim CS, Davies AH. Post Thrombotic Syndrome. Adv Exp Med Biol 2017;906:363-75.
  15. Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong Dle T, Amoura Z, et al. Immunosuppressants reduce venous thrombosis relapse in Behçet’s disease. Arthritis Rheum 2012;64: 2753-60.
  16. Onder M, Gürer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001;15:126-36.